Partner Headlines - ICPT

  1. Conatus Pharma Skyrockets On Novartis NASH Liver Drug Licensing ...

    Investors Business Daily
  2. Can-Fite An Emerging NASH Play With CF102

    TalkMarkets
  3. 5 Biotech Stocks to Watch as Interest in NASH Increases

    TalkMarkets
  4. Keep an Eye on These 7 Stocks for February 16, 2016

    Benzinga
  5. Benzinga's Weekend M&A Chatter

    Benzinga
  6. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD
  7. Intercept Pharmaceuticals Soars 30%; Reuters Reported Company ...

    Benzinga
  8. Benzinga's Top Upgrades

    Benzinga
  9. BioMarin, Intercept hit by FDA

    IBD
  10. BioMarin, Intercept Pharma Drugs Face FDA Delays

    IBD
  11. INTERCEPT PHARMA

    IBD
  12. Intercept Pharma Higher On Takeover Rumor

    Benzinga
  13. Intercept Presents New Data Analyses on Non-Invasive Liver Testing ...

    Benzinga
  14. Intercept Presents New Primary Biliary Cholangitis Data at AASLD ...

    Benzinga
  15. Benzinga's M&A Chatter for Tuesday November 10, 2015

    Benzinga
  16. Intercept Pharmaceuticals

    IBD
  17. Intercept Pharmaceuticals Rebounds After Phase 2 Trial Of OCA ...

    Benzinga
  18. Intercept Pharma NASH Drug Disappoints In Japan

    IBD
  19. Mid-Morning Market Update: Markets Open Higher; Hershey Earnings ...

    Benzinga
  20. Morning Market Losers

    Benzinga
  21. Mid-Morning Market Update: Markets Open Lower; Carlyle Group ...

    Benzinga
  22. Morning Market Gainers

    Benzinga
  23. FDA Grants Priority Review for Intercept's Obeticholic Acid for ...

    Benzinga
  24. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga
  25. Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's ...

    Benzinga
  26. Benzinga's Top Initiations

    Benzinga
  27. Barclays Initiates Intercept Pharmaceuticals With Overweight

    Benzinga
  28. Intercept Pharmaceuticals Inc (ICPT) Moves Forward With OCA REGENERATE ...

    GuruFocus
  29. Intercept has a design for test

    IBD
  30. Intercept's NASH Trial Design Irks Investors

    IBD
  31. Will The Bulls In Options Continue To Be Disappointed This Week?

    Benzinga
  32. Analysts are Positive on Intercept Pharmaceuticals Inc Following ...

    GuruFocus
  33. Earnings Scheduled For March 2, 2015

    Benzinga
  34. Making Money With Charles Payne: 02/06/15

    FoxBusiness
  35. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals ...

    GuruFocus
  36. Cowen And Company Analyst Explains Why Intercept Pharmaceuticals ...

    Benzinga
  37. Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals ...

    Benzinga
  38. Mid-Afternoon Market Update: Crude Oil Jumps 7.5%; Visa Shares ...

    Benzinga
  39. Intercept Pharmaceuticals Soars 20%, Possible Short Squeeze

    Benzinga
  40. Mid-Day Market Update: Amazon Jumps On Upbeat Earnings; Hawaiian ...

    Benzinga
  41. Intercept Pharmaceuticals (ICPT) Obeticholic Acid Momentum, Gigamon ...

    GuruFocus
  42. Benzinga's Volume Movers

    Benzinga
  43. Mid-Morning Market Update: Markets Drop; Mastercard Profit Tops ...

    Benzinga
  44. Morning Market Gainers

    Benzinga
  45. Friday Morning Movers: Amazon Pops, Deckers Outdoor Plummets ...

    Benzinga
  46. Stock Futures Sharpen Losses; Amazon, Visa, MasterCard Climb

    IBD
  47. Benzinga's Top #PreMarket Gainers

    Benzinga
  48. INTERCEPT PHARMACEUTICALS

    IBD
  49. Deutsche Bank: No Big Move In FY15 For Intercept Pharmaceuticals

    Benzinga
  50. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  51. Gilead Acquires Drug Program For Fatty Liver Disease

    IBD
  52. IPO Stock Watch: FibroGen Up With Liver-Disease Field

    IBD
  53. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  54. Intercept Announces Publication Of Meta-Analysis From The Global ...

    Benzinga
  55. Here Are The Top 25 Analysts On Wall Street

    Benzinga
  56. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  57. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  58. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  59. Morning Market Losers

    Benzinga
  60. Benzinga's Top #PreMarket Losers

    Benzinga
  61. Meet The 5 Companies Loving Obamacare

    Benzinga
  62. Morning Market Losers

    Benzinga
  63. Benzinga's Top #PreMarket Losers

    Benzinga
  64. Benzinga's Top Initiations

    Benzinga
  65. Cowen Initiates Intercept At Outperform

    Benzinga
  66. Four biotech takeover targets?

    IBD
  67. 4 Biotechs That Might Be Bought Soon

    IBD
  68. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  69. Morning Market Losers

    Benzinga
  70. Benzinga's Top #PreMarket Losers

    Benzinga
  71. CNBC's Stock Pops & Drops From August 12

    Benzinga
  72. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  73. U.S. Job Openings Climb; Leerink Swann Bullish On Intercept Pharmaceuticals

    Benzinga
  74. U.S. Stocks Fall; Dealertrack Shares Surge On Upbeat Results

    Benzinga
  75. Markets Mostly Flat; Flowers Foods Profit Misses Estimates

    Benzinga
  76. Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain

    IBD
  77. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  78. Benzinga's Volume Movers

    Benzinga
  79. Morning Market Movers

    Benzinga
  80. Conatus Shares Move Higher On Industry Data

    Benzinga
  81. Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars

    IBD
  82. Benzinga's Top #PreMarket Gainers

    Benzinga
  83. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  84. INTERCEPT PHARMACEUTICALS

    IBD
  85. Intercept Pharmaceutical's Shares Soar On Earnings

    Benzinga
  86. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  87. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  88. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  89. Benzinga's Top Initiations

    Benzinga
  90. Analysts Comment On Intercept Amid Share Decline Following FLINT ...

    Benzinga
  91. Top Healthcare Movers For June 9, 2014

    Benzinga
  92. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  93. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., ...

    GuruFocus
  94. Intercept Issues Preclinical Data Showing OCA's Potential Role ...

    Benzinga
  95. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  96. Market Wrap For March 17: Investors Focused On Economic Data ...

    Benzinga
  97. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  98. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  99. Top Trending Tickers On StockTwits For March 17

    Benzinga
  100. Benzinga's Top #PreMarket Losers

    Benzinga
Trading Center